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Background. Occult chronic kidney disease (OCKD) and 
cardiovascular risk (CVR) share risk factors that trigger 
chronic degenerative diseases. Aim. To assess the associa-
tion of OCKD with CVR and its risk factors in a sample of 
university workers. Material and methods. This is a cross-
sectional study. From 89 volunteers the lipid profile, glu-
cose, urea, creatinine and uric acid were obtained from 
blood as well as anthropometric measures and blood 
pressure. They were classified by their CVR calculated by 
the Framingham equation, into the groups: with-CVR and 
without-CVR; and by their glomerular filtration rate (GFR) 
into: with-OCKD and without-OCKD. Then into sub-
groups of each CVR factor (CVRF): sex, smoking, diabetes 
mellitus (DM) and hypertension. The statistical differences 
between groups (p <0.05) and the correlation between 
CVR and GFR and the odds ratio (OR) for each CVRF were 
determined. Results. A negative correlation between the 
OCKD and the CVR was obtained for men (ρ = - 0.743, p 
= 0.000) and women (ρ = - 0.874, p = 0.000). The overall 
prevalence of hypertension was 23.6% (OR = 15.43 for 
CVR, 95% CI, 4.04 - 58.95, OR = 14.75 for OCKD, 95% 
CI 2.76 - 78.23) and older than 50 years of 33.7% (OR for 
CVR = 20.37, 95% CI, 6.25 - 66.43). Conclusions. OCKD 
is strongly associated with the CVR. Furthermore, each 
CVRF impacts in different range and level to the develop-
ment of cardiovascular disease and kidney failure.
Keywords. Occult chronic kidney disease, cardiovascular risk, 
glomerular filtration rate, hypertension, diabetes mellitus.
n Mexico among the most frequent causes of death 
in people at productive and at post-productive age 
are cardiovascular (CVD) and related diseases such 
as diabetes mellitus (DM), hypertension and ischemic 
heart disease1-3. 
It is widely known that classical cardiovascular risk factors 
(CVRF), such as smoking, hypertension, DM and elevated 
non-HDL cholesterol, produce structural and functional 
changes in the endothelium, causing its chronic inflam-
mation and its dysfunction, characterized by reduced bio-
availability of the vasodilator nitric oxide (NO). These fac-
tors generate a vasculature highly susceptible to rupture 
of the atherosclerotic plaque and thus significantly elevate 
the cardiovascular risk (CVR)4. 
The occult chronic kidney disease (OCKD), which involves 
a decrease in the glomerular filtration rate (GFR), is a ma-
jor public health problem that recently has increased its 
incidence. Since the OCKD comes along with a high CVR, 
it is important in the clinical practice to evaluate both in 
order to establish the best treatment5. There are several 
equations for measuring GFR; one of these is the Jelliffes 
equation, which considers serum creatinine, sex and age 
as the most important variables6. 
Tobacco smoking alters the hemodynamic balance, affect-
ing blood pressure, cholesterol levels, oxygen transport 
and homeostasis in the systems of coagulation and in-
flammation. Because of this, it is attributed that 25-30% 
of tobacco deaths are due to CVD7-10, there is also evi-
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dence that women smokers who take oral contraceptives 
increase their RCV and they tend to have an early onset 
of menopause. Quitting smoking reduces this risk and im-
proves the prognosis of CVD regardless of the duration of 
the habit11. 
Hypertension is a major public health problem and its eti-
ology, diagnosis and control are not yet well understood. 
It is associated with multiple risk factors such as obesity, 
dyslipidemia, hypernatremia and insulin resistance. It is 
known that the rise in the production of reactive oxy-
gen species oxidize the endothelial NO, but it can also 
be caused by hyperinsulinemia, as insulin also acts as a 
vasodilator and therefore in a state of insulin resistance, 
the vasoconstrictor endothelin-1 is produced and conse-
quently this generates endothelial dysfunction12,13.
Hyperglycemia in DM is the cause of the microangiopathic 
complications, increasing the production of reactive oxy-
gen species and inflammatory intermediates. It also in-
terferes with insulin signaling and promotes endothelial 
dysregulation4,12. 
Cholesterol is an important structural component of cell 
membranes, hormones and bile acids and it is transported 
in the blood attached to lipoproteins. Elevated levels of 
low density (LDL) lipoproteins and low levels of high-den-
sity (HDL) are associated with CVD, because of the highly 
atherogenic and oxidazable nature of LDL14. Moreover it 
has been demonstrated that alone low levels of HDL are 
predictors of CVD15. 
Since OCKD and CVD share most risk factors, it is impor-
tant to find the relationship between the pathological 
processes of the CVRF towards the development of CVD 
and OCKD. Thus, the aim of this study was to assess the 
association of occult chronic kidney disease (OCKD) with 
cardiovascular risk (CVR) and its risk factors (CVRF) in a 
sample of university workers.
Population
This was a cross-sectional study. 200 workers from the 
Autonomous University of the State of Mexico of the city 
of Toluca were invited to participate. Their selection was 
according to their CRF: age, sex, hypertension, tobacco 
smoking and DM. None of the volunteers had any car-
diac, hepatic nor renal condition, cancer, autoimmune 
diseases, infectious processes, pregnancy nor was taking 
anti-inflammatory drugs, antihistamic, or lipid-lowering 
medication on a regular basis. The research protocol met 
the ethical standards of the Declaration of Helsinki and 
was approved by the Ethics and Research Committee of 
the Medical Sciences and Research Center. The 114 vol-
unteers who agreed to participate gave their informed 
consent and a validated questionnaire about lifestyle and 
health conditions16. 
Blood sample collection
Blood samples were collected after a fasting period of 12 
hr. Glucose levels were measured by the glucose hexoki-
nase method (Randox). Urea, creatinine, and uric acid, 
were assayed with colorimetric methods (Randox). For the 
lipid profile, triglycerides (TG) were determined by their 
enzymatic hydrolysis and then followed by a colorimetric 
reaction, HDL and LDL lipoproteins were measured using 
a clearance method and total cholesterol (TC) with an en-
zymatic colorimetric method (Randox)16,17. 
Study Groups
Using the information obtained from questionnaires, the 
results of anthropometric measurements and the blood 
tests; volunteers were grouped as follows: 
Cardiovascular risk. The percentage of RCV was calculated 
using with the Framingham equation up to ten years18,19 
and validated for Hispanics20. The cutoff points used were 
≤10% for group without cardiovascular risk (without-CVR) 
and >10% for the group with cardiovascular risk (with-
CVR)21-23. Smokers and diabetics were excluded from the 
group without-CVR to avoid interference of these factors 
on the results.
Subgroups
Occult chronic kidney disease. It was calculated with the 
formula for the glomerular filtration rate of Jelliffes6, tak-
ing <60mL/min/1.73m2 as the cutoff for OCKD. 
Age. The selected cutoff was of 50 years old or more. 
Tobacco smoking. Were considered smokers those volun-
teers who smoked at least one cigarette a week or more 
than four per month. 
Diabetes mellitus. Volunteers classified as diabetics were 
those who reported it in the questionnaire or those that 
glucose measurements in their blood sample exceeded 
120 mg/dL. 
Hypertension. Blood pressure was measured by a sphyg-
momanometer. Three measurements were taken and the 
average of the last two was reported. An optimal-normal 
pressure was considered as systolic <129 mm Hg or dia-
stolic <84 mm Hg and for hypertension was systolic ≥130 
mm Hg or diastolic ≥85. When the systolic or diastolic 
pressure fell into different categories, the highest category 
was selected for classification. It was not considered the 
intake of antihypertensive drugs. 
Overweight and obesity. The body mass index (BMI) was 
calculated. The weight was measured using a body compo-
sition analyzer (Tanita), and height with a conventional sta-
diometer. BMI over 26 was considered overweight-obesity.
Menopause-postmenopause. Female volunteers that in 
the questionnaire reported this.
Statistical analysis
Microsoft Office Excel 2007 was used to calculate the 
RCV of the Framingham equation. The questionnaire data 
and blood tests results were analyzed using the statistical 
package PAWS Statistics version 18.0. Descriptive statistics 
were obtained for all continuous variables. The distribu-
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tion of data was assessed using the Shapiro-Wilk test for 
normality and the Levene test for homogeneity both with 
a significance of p ≤ 0.05, depending on the results it was 
determined the proper statistical comparison test (Student 
t test for parametric data and test Mann-Whitney test for 
nonparametric data) between groups of RCV and OCKD. 
The association between the RCV and OCKD was tested 
with the Spearman correlation coefficient between the 
Framingham and Jelliffes equations. We calculated the 
odds ratio (OR) of each subgroup towards the develop-
ment of a high CVR and OCKD. 
he number of volunteers who met the inclusion 
criteria was 89 individuals, 52 women (42.73 ± 
9.7 years) and 37 men (50.65 ± 10.3 years). It 
was observed (Table 1) that in men the average levels of 
CT are about 8 units above the recommended levels (200 
mg/dL) and that there is a wide dispersion of its values  in 
both sexes. LDL averages are above the standard param-
eters (up to 130 mg/dL) and HDL are below recommended 
values  (>55 mg/dL in men and >65 mg/dL in women).
45.9% of men and 23.1% of women belonged to the 
with-CVR group (>10% of score Framinham), while the 
incidence of OCKD in men was 7.4% and 11.1% in wom-
en (Figure 1).
The correlation analysis (Figures 2 and 3) indicated a strong 
negative relationship between the Jelliffes equation for cal-
culating the GFR and Framingham equation for CVR for 
both women (ρ =- 0.874, p = 0.000) and men (ρ =- 0.743, 
p = 0.000).
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Figure 1. Clasification of volunteers by cardiovascular risk and 
cardiovascular risk factors (women: n=52; men: n=37).
Table 1. Blood test results of volunteers (women: n=52; 
men: n=37).
Parameter Sex Mean ± SD
Glucose (mg/dL)
Women 91.46 ± 15.43
Men 107.41 ± 36.20
Urea (mg/dL)
Women 24.35 ± 5.96
Men 30.71 ± 5.26
Creatinine (mg/dL)
Women 0.92 ± 0.88
Men 1.10 ± 0.20
Uric acid (mg/dL)
Women 3.38 ± 0.83
Men 5.29 ± 1.20
TG (mg/dL)
Women 136.60 ± 77.11
Men 180.68 ± 93.07
CT (mg/dL)
Women 190.31 ± 42.62
Men 207.70 ± 33.02
HDL (mg/dL)
Women 44.31 ± 10.23
Men 41.46 ± 8.99
LDL (mg/dL)
Women 97.90 ± 28.07
Men 109.62 ± 21.88
Figure 2. Bivariate correlation analysis between Framingham 
and Jelliffes equation for women.
Figure 3. Bivariate correlation analysis between Framingham 
and Jelliffes equation for men.
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The comparison of the continuous variables between 
groups indicated significant differences in CVR for men 
when considering the age. In women differences were 
found in age, levels of glucose and TG, TC and LDL. In 
the OCKD groups differences for men and women were 
found in age, and in women only with elevated glucose 
and creatinine decreased (Table 2).
OR analysis between groups of CVR indicated that each of 
the factors impacted with a different magnitude, greatly 
increasing the CVR the age over 50 years and hyperten-
sion. It was found that men had a higher CVR and also 
for them the factor with a greater impact is age, followed 
by hypertension, tobacco smoking, and finally DM. In 
women was found that menopause-postmenopause, hy-
pertension and DM are the factors that by far increase 
CVR. The results pointed that hypertension was the fac-
tor with the greatest impact towards the development of 
OCKD (Table 3).
Table 2. Descriptive statistics of continous variables by groups of CVR and OCKD for men and women.
Parameter Sex
With-CVR Without-CVR
p≤0.05
With-OCKD Without-OCKD
p≤0.05
Mean ± SD Mean ± SD Mean ± SD Mean ± SD
Age (years)
Women 54.42 ± 3.75 39.23 ± 8.03 0.0001* 57.29 ± 3.09 40.29 ± 8.48 0.000 1*
Men 57.06 ± 8.76 45.2 ± 8.15 0.000 1* 73.00 ± 7.07 49.75 ± 8.94 0.001 1*
Glucose (mg/dL)
Women 104.08 ± 24.16 87.68 ± 9.12 0.0042* 110.00 ± 28.86 88.29 ± 10.34 0.001 1*
Men 119.47 ± 49.83 97.15 ± 12.27 0.390 2 110.50 ± 30.41 107.38 ± 37.95 0.910 1
Urea (mg/dL)
Women 25.63 ± 6.22 23.97 ± 25.91 0.4221 26.14 ± 6.57 24.05 ± 5.88 0.396 1
Men 31.50 ± 5.79 30.00 ± 4.80 0.4151 31.50 ± 6.36 30.66 ± 5.30 0.830 1
Creatinine (mg/dL)
Women 0.92 ± 0.08 0.92 ± 0.09 0.9421 0.87 ± 0.06 0.93 ± 0.09 0.088 1*
Men 1.06 ± 0.11 1.14 ± 0.26 0.2251 0.96 ± 0.07 1.11 ± 0.20 0.089 2
Uric acid (mg/dL)
Women 3.79 ± 0.97 3.25 ± 0.76 0.0621 3.56 ± 0.86 3.34 ± 0.83 0.524 1
Men 5.11 ± 1.48 5.46 ± 0.92 0.4241 4.02 ± 1.20 5.37 ± 1.18 0.128 1
TG (mg/dL)
Women 189.00 ± 101.32 120.88 ± 61.50 0.011 2* 167.71 ± 86.26 132.98 ± 78.17 0.290 1
Men 188.00 ± 90.64 174.45 ± 96.99 0.752 2 181.00 ± 100.41 180.38 ± 96.39 0.993 1
CT (mg/dL)
Women 217.42 ± 53.66 182.18 ± 35.62 0.013 2* 193.29 ± 29.50 187.98 ± 44.90 0.765 1
Men 216.94 ± 33.23 199.85 ± 31.53 0.118 1 197.50 ± 4.95 208.16 ± 34.14 0.667 1
HDL (mg/dL)
Women 41.17 ± 7.76 45.25 ± 10.76 0.229 1 43.86 ± 5.84 42.83 ± 8.95 0.772 1
Men 41.76 ± 8.02 41.2 ± 9.93 0.852 1 40.00 ± 4.24 40.59 ± 8.89 0.927 1
LDL (mg/dL)
Women 114.5 ± 37.16 92.93 ± 23.04 0.041 2* 96.00 ± 19.01 96.93 ± 29.59 0.937 1
Men 115.47 ± 22.2 104.65 ± 20.86 0.136 1 104.00 ± 8.49 109.31 ± 22.27 0.742 1
(*) Statistically significant; (1) T-Student test; (2) U Mann-Whitney test
Table 3. OR of classical risk factors towards the development of cardiovascular disease and occult chronic kidney disease.
Group Variable OR for CVR (95% CI) OR for OCKD (95% CI)
Total simple
Age over 50 years old 20.37 (6.25 – 66.43) SNS
Hipertension 15.43 (4.04 – 58.95) 14.75 (2.76 – 78.23)
Male sex 2.83 (1.14 – 7.10) SNS
Men
Age over 50 years old 9.75 (2.15 – 44.14) SNS
Hipertension 1.89 (1.21 – 2.96) SNS
Tobacco smoking 1.89 (1.21 – 2.96) SNS
Diabetes mellitus 1.70 (1.41 – 2.53) SNS
Women
Menopause-postmenopause 9.00 (2.03 – 39.93) 12.92 (1.41 – 118.61)
Hipertension 7.94 (1.88 – 33.45) 29.14 (3.02 – 281.5)
Diabetes mellitus 1.50 (1.01 – 2.24) 16.00 (1.22 – 209.93)
SNS: statistically not significant
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n a population that reflects a sector of society with 
a moderate standard of living and income, such as 
university workers, a high prevalence of hyperten-
sion was observed, as well as high prevalence of 
obesity, overweight, and smoking that are CVD prevent-
able factors. So the wide dispersion of these parameters is 
attributed to the large interindividual variability. Nonethe-
less, the Framingham equation allowed to properly clas-
sify the volunteers according to their CVR, showing that 
it is appropriate to use it in the Mexican population. Due 
to the low number of participants, diabetics and smok-
ers were excluded from the group without-CVR to avoid 
losing significance in the subsequent analysis. However, 
it should be noted that these had low percentage of risk 
due mainly to its relatively young age.
It is alarming to note that men have high cholesterol lev-
els regardless of the level of CVR, indicating a propensity 
to develop atherosclerotic plaques, which increases with 
age, similar to what the Framingham equation poses.
The high incidence of overweight and obesity combined 
with elevated cholesterol levels indicates a high probabil-
ity of developing CVD, especially with aging and the inci-
dence of other CVRF as smoking, hypertension, diabetes 
mellitus and a diet high in fat and low in fiber and anti-
oxidants. Due to the presence of receptors, the adipose 
tissue responds to physiological and metabolic processes 
of various organs including the CNS by modulating the 
secretion of adipocytokines such as adiponectin, which 
has antiatherogenic, anti-inflammatory, and antidiabetic 
properties. This cytokine improves insulin sensitivity and 
activates the NO synthesis which protects the vasculature. 
The CVRF decrease the adiponectin levels, promoting a 
proinflammatory state and the development of related 
pathologies23-26.
The bivariate correlation analysis showed that a decrease 
in the GFR and increased CVR are closely linked, so it is as-
sumed that both share risk factors and surely some meta-
bolic pathways. Similar findings were observed in the study 
of Buitrago F. et al. OCKD was present in high CVR people 
calculated from the Framingham equation, and moreover 
it was associated with high BMI and older age27.
This study shows that age, hypertension, and to a lesser 
extent DM and smoking were the factors that influenced 
more on the classification of people with CVR. These fac-
tors impact in different sizes and at different levels to the 
development of CVR between both sexes. Men had a risk 
approximately 3 times higher than women to develop 
high CVR and for men older than 50 years the risk in-
creased about 10 times and nearly double in those who 
had hypertension, DM or smoking habits. These are lower 
values  than those reported by Tartaglione et al. For adult 
men with hypertension (OR = 2.3, 95% CI, 1.3-3.9), DM 
(OR = 4.5, 95% CI, 2.1-9.8) and smoking (OR = 1.48, 
95% CI, 0.97-2.28) [28]. In contrast, women showed an 
increased risk of CVD after menopause and in those who 
had hypertension and DM.
Menopausal women who have an increased CVR suffer 
heart attacks more severe than men. After a heart attack, 
the chance of dying within a year increases by 50% com-
pared to men and the risk of a second attack is two times 
higher in the next six years29. This is due to a depressed 
estrogen synthesis. It is well known that estrogens play a 
protective role by participating in the metabolism of lipo-
proteins (diminish LDL and raise HDL and apolipoprotein 
A1), in the process of hemostasis (modulate the release of 
prostacyclin, NO, endothelin, thrombomodulin and hepa-
ran sulfate in the endothelium), and in the responses of 
smooth muscle cells towards the blood pressure (avoid con-
traction by inhibition of K+ channels and Ca2+ L-type) [30].
It can be deduced from the pathological process of CVD 
and OCKD that the risk factors are involved not only into 
the frequency and severity in which they affect the indi-
vidual health, but also they are key factors for the preven-
tion, mainly those with greater impact as hypertension, so 
preventing and controlling this risk factor, it is possible to 
prevent both conditions: CVD and OCKD. On the other 
hand, it is not possible to take control of non-modifiable 
factors (sex, age, DM), but it is possible to take preventive 
measures to compensate the endothelial damage, espe-
cially involving the smoking habits, a sedentary lifestyle 
and an unbalanced diet. 
It is relevant to point out that subjects with CVR should 
consider the physician recommendations according to age, 
family history and underlying diseases of each person.
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